Literature DB >> 1883327

5-Lipoxygenase is not essential in macrophage-mediated oxidation of low-density lipoprotein.

W Jessup1, V Darley-Usmar, V O'Leary, S Bedwell.   

Abstract

The concentration-dependent effects of a series of lipoxygenase inhibitors and antioxidants on the macrophage-mediated oxidative modification of low-density lipoprotein (LDL) were measured. Their influence on macrophage 5-lipoxygenase pathway activity was also studied over the same concentration range. No correlation between inhibition of 5-lipoxygenase and of macrophage-mediated oxidation of LDL was observed. The capacity of the compounds to prevent cell-mediated modification of LDL could be explained in terms of their activity as either aqueous- or lipid-peroxyl radical scavengers. Two potent 5-lipoxygenase inhibitors (MK 886 and Revlon 5901), which had no radical-scavenging properties, were unable to block LDL modification. It is concluded that 5-lipoxygenase is not essential for LDL oxidation by macrophages.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1883327      PMCID: PMC1151463          DOI: 10.1042/bj2780163

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Free radicals and low-density lipoprotein oxidation by macrophages.

Authors:  G M Wilkins; D S Leake
Journal:  Biochem Soc Trans       Date:  1990-12       Impact factor: 5.407

2.  A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.

Authors:  S Parthasarathy; E Wieland; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  The modification of low density lipoproteins by macrophages by oxidation or proteolysis.

Authors:  S M Rankin; D S Leake
Journal:  Agents Actions Suppl       Date:  1988

4.  A method for the comparative assessment of antioxidants as peroxyl radical scavengers.

Authors:  V M Darley-Usmar; A Hersey; L G Garland
Journal:  Biochem Pharmacol       Date:  1989-05-01       Impact factor: 5.858

5.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

Authors:  D W Bilheimer; S Eisenberg; R I Levy
Journal:  Biochim Biophys Acta       Date:  1972-02-21

6.  Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification.

Authors:  C P Sparrow; S Parthasarathy; D Steinberg
Journal:  J Lipid Res       Date:  1988-06       Impact factor: 5.922

7.  Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.

Authors:  J E Tateson; R W Randall; C H Reynolds; W P Jackson; P Bhattacherjee; J A Salmon; L G Garland
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

8.  Lipid peroxyl radical intermediates in the peroxidation of polyunsaturated fatty acids by lipoxygenase. Direct electron spin resonance investigations.

Authors:  W Chamulitrat; R P Mason
Journal:  J Biol Chem       Date:  1989-12-15       Impact factor: 5.157

9.  Continuous monitoring of in vitro oxidation of human low density lipoprotein.

Authors:  H Esterbauer; G Striegl; H Puhl; M Rotheneder
Journal:  Free Radic Res Commun       Date:  1989

10.  Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation.

Authors:  U P Steinbrecher; M Lougheed; W C Kwan; M Dirks
Journal:  J Biol Chem       Date:  1989-09-15       Impact factor: 5.157

View more
  11 in total

1.  Pro-oxidant effects of lipoxygenase-derived peroxides on the copper-initiated oxidation of low-density lipoprotein.

Authors:  V J O'Leary; V M Darley-Usmar; L J Russell; D Stone
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

2.  Novel cell culture medium for use in oxidation experiments provides insights into mechanisms of endothelial cell-mediated oxidation of LDL.

Authors:  T R Dugas; D W Morel; E H Harrison
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-10       Impact factor: 2.416

3.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.

Authors:  A Daugherty; J L Dunn; D L Rateri; J W Heinecke
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

4.  Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper.

Authors:  K L Carpenter; G M Wilkins; B Fussell; J A Ballantine; S E Taylor; M J Mitchinson; D S Leake
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

5.  Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages.

Authors:  L J Hazell; R Stocker
Journal:  Biochem J       Date:  1993-02-15       Impact factor: 3.857

6.  Human macrophage-mediated oxidation of low-density lipoprotein is delayed and independent of superoxide production.

Authors:  B Garner; R T Dean; W Jessup
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

7.  Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions.

Authors:  C Smith; M J Mitchinson; O I Aruoma; B Halliwell
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

8.  Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein.

Authors:  S Ylä-Herttuala; J Luoma; H Viita; T Hiltunen; T Sisto; T Nikkari
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

9.  Neutrophil-oxidized low density lipoprotein: generation in and clearance from the plasma.

Authors:  P Görög
Journal:  Int J Exp Pathol       Date:  1992-08       Impact factor: 1.925

Review 10.  Leukotriene signaling in atherosclerosis and ischemia.

Authors:  Magnus Bäck
Journal:  Cardiovasc Drugs Ther       Date:  2008-10-24       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.